Tamiflu User Severe Reaction
Tamiflu User Has Severe Reaction. A 19-year-old British girl treated with Tamiflu has developed Stevens-Johnson syndrome and toxic epidermal necrolysis. The woman, Samantha Millard, was put on life support within 72 hours of taking ‘Tamiflu’, and is now blind. Stevens-Johnson syndrome and toxic epidermal necrolysis are two forms … [Read more...]
Tamiflu Dosing Error Warning Issued by FDA
Tamiflu Dosing Error Warning. The U.S. Food & Drug Administration (FDA) has issued a Public Health Alert advising pharmacists and pediatrics healthcare professionals about potential dosing errors with Tamiflu (oseltamivir) for Oral Suspension. The FDA stated that U.S. health care providers typically write prescriptions for … [Read more...]
Relenza Side Effects Probes
Health Canada is looking into reports that Relenza, a drug used to treat the flu, has been linked to deaths and abnormal behavior in children. In November 2007, a US Food & Drug Administration (FDA) advisory panel had recommended stronger warnings about psychiatric side effects be added to the labeling of Relenza and another … [Read more...]
Tamiflu Resistant Flu More Common
Some current influenza viruses are carrying a mutation—A/H1N1-H274Y—that makes them resistant to Tamiflu. The Centers for Disease Control and Prevention (CDC) estimate that a small sampling of flu viruses nationwide carry the mutation. The Tamiflu resistant mutation has occurred in A/H1N1, one of the main circulating strains causing … [Read more...]
Tamiflu and Relenza Stronger Warnings
Tamiflu and Relenza, drugs used to treat the flu, should bear warnings about possible psychiatric side effects, a Food & Drug Association (FDA) panel said yesterday. The recommendation came in the wake of a number of reports that both Tamiflu and Relenza had been linked to episodes of abnormal behavior that included delirium … [Read more...]
New Tamiflu Warning
New Warning Regarding Tamiflu. The popular antiviral drug Tamiflu is under fire again, this time from Health Canada. The Canadian government issued a new safety advisory today, warning consumers that Tamiflu may be linked to hallucinations and abnormal behavior, including self harm. In conjunction with the new warning, Health … [Read more...]
FDA Tamiflu Behavior Warning
Tamiflu To Carry Behavior Warning. Food and Drug Administration staff recommend that the label for Roche Holding AG's (RHHBY) flu drug Tamiflu be updated to include a precaution related to possible psychiatric problems in patients who take it. The staff's recommendation, posted on the FDA's Web site Monday, follows a 10-month … [Read more...]
